Viewing Study NCT00238251


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-02-22 @ 7:02 AM
Study NCT ID: NCT00238251
Status: COMPLETED
Last Update Posted: 2012-06-05
First Post: 2005-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases
Sponsor: Swiss Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module